A securities class action lawsuit against Ardent Health, Inc. (ARDT) has been filed following significant negative disclosures that triggered a sharp decline in the company's stock price. On November 12, 2025, Ardent Health announced a $43 million revenue decrease and reduced its 2025 EBITDA guidance by $57.5 million, while simultaneously increasing professional liability reserves by $54 million. These developments were not previously disclosed to investors, forming the basis of the securities fraud allegations.
The stock market responded sharply to the announcement, with shares declining 34 percent from $14.05 to $9.30 per share on the disclosure date. Investors who sustained substantial losses during the relevant period are being notified of their right to participate in the litigation. Shareholders with losses exceeding $100,000 are eligible to apply for lead plaintiff status in the class action.
Investors seeking to file lead plaintiff applications must submit their paperwork by March 9, 2026. Lead plaintiff status allows shareholders with significant financial exposure to represent the broader class of affected investors and oversee the litigation proceedings. Legal counsel specializing in securities claims can provide guidance on the application process and timeline requirements for interested parties.